Einstein-Rockefeller-Hunter Center for AIDS Research

Overview

As the AIDS research community and public health systems locally, nationally and globally focus efforts on preventing HIV transmission and ending the epidemic, it is critical to integrate our efforts across institutions and disciplines, sharing resources among many researchers to achieve the greatest gain in scientific understanding. Our strategic planning process made clear that the greatest contribution of a New York City-based Center for AIDS Research (CFAR) would be achieved by synergizing the scientific strengths, research expertise and clinical resources of three major NYC academic institutions, the Albert Einstein College of Medicine (Einstein), the Rockefeller University (Rockefeller) and the School of Urban Public Health at Hunter College, City University of New York (Hunter).

Thus, the Einstein/Rockefeller/Hunter (ERH)-CFAR was created as a highly synergistic new partnership of non-overlapping complementary resources. The ERH-CFAR links a strong basic and clinical research institution (Einstein) with a large patient base of HIV-infected individuals, a globally pre-eminent basic science institution (Rockefeller), and a strong public health/implementation science institution (Hunter) to catalyze research to prevent, treat and eradicate HIV infection and thereby end the epidemic. The ERH-CFAR is structured to drive extensive collaborations across disciplines and institutions and coordinate a research agenda by ERH-CFAR investigators focused on “bench to bedside to community and back to the bench” research to achieve our mission, to arrest the AIDS epidemic.

A major focus of our efforts are to improve utilization of current treatments and to develop new therapies, such as potent broadly neutralizing antibodies, for prevention, reducing the incidence of new infections; treatment, improving treatment outcomes among infected individuals and reducing transmission; and eradication of HIV reservoirs. In addition to developing novel therapeutic approaches, our investigators are optimizing the translation of scientific breakthroughs into reality by identifying and implementing the most effective strategies to deliver treatments shown to be efficacious in clinical and bench research.

Einstein Logo 

Rockefeller Logo 

Hunter Logo 

ERH-CFAR at a Glance

Partner Institutions 

  • Albert Einstein College of Medicine
  • Rockefeller University
  • School of Urban Public Health at Hunter College
 

Investigators 

Total ERH-CFAR members

  • 144 Full members
  • 8 Affiliate members

CFAR member trainees funded by NIH K awards

  • 15 Full members
 

NIH Funding 

FY2014 OAR NIH AIDS FRB grants

$35,160,683 Total costs

 

New NIH AIDS grants awarded in FY2015

$3,394,920 Total costs

 

FY2014 non-AIDS NIH grants

$34,745,334 Total costs

 

Publications (first 6 months of 2015) 

Total Publications: 253

Publications multi-authored
by ERH-CFAR members: 76

Cores 

Administrative

Director: Dr. H. Goldstein

 

Developmental

Directors: Dr. V. Prasad & Dr. C. Cunningham

 

Biomarkers & Advanced Technologies

Directors: Dr. J. Berman & Dr. S. Almo

 

Behavioral Science

Director: Dr. L. Bauman

 

Clinical Translational Implementation Science

Director: Dr. K. Anastos

 

Scientific Working Groups 

HIV and Eradication

Directors: Dr. G. Kalpana & Dr. M. Caskey

 

HIV and Aging

Directors: Dr. J. Vergherse & Dr. J. Berman

 

Patient and Population Health Outcomes Research

Directors: Dr. J. Arnsten & Dr. D. Nash

 
Click here to log in